The adjuvant use of plasma rich in growth factors in the inferior alveolar nerve repositioning technique

PURPOSE: To describe the outcomes of the adjuvant use of plasma rich in growth factors (PRGF) in the inferior alveolar nerve repositioning surgery. MATERIAL AND METHODS: A retrospective report of three cases was conducted in a single private dental clinic. The variables were the residual alveolar bone height, the surgical complications, the occurrence of neurosensory complications, the marginal bone stability and the implant survival. A descriptive statistical analysis was performed. RESULTS: Three inferior alveolar repositioning were performed with the adjuvant use of PRGF. The residual alveolar bone height was 2.2 ± 0.14 mm. All patients underwent uneventful healing with no symptoms of neurosensory complications neither implant failure. The marginal bone loss was 0.1 ± 0.4 mm CONCLUSIONS: The preventative and adjuvant use of PRGF in inferior alveolar nerve repositioning need to be assessed in prospective studies with a larger sample size.